BioNTech SE Noncurrent Contract Liabilities
BioNTech SE (BNTX) had Noncurrent Contract Liabilities of EUR 88.00 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:NoncurrentContractLiabilities · last filed 2026-03-10
- 2025-12-31: Noncurrent Contract Liabilities 88.00M EUR.
- 2024-12-31: Noncurrent Contract Liabilities 183.00M EUR.
- 2023-12-31: Noncurrent Contract Liabilities 398.50M EUR.
- 2022-12-31: Noncurrent Contract Liabilities 48.40M EUR.
| Period end | Noncurrent Contract Liabilities | Noncurrent Contract Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 88.00M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 183.00M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 398.50M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 48.40M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 9.00M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 71.90M EUR 20-F/A · filed 2022-10-26 | 71.89M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 97.11M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 205.65M EUR 20-F · filed 2020-03-31 |